Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

Category: Disclosures

[Disclosure] Hanamicron(067310) Receives Conversion Request for 43.2B KRW in Convertible Bonds

[Disclosure] Hanamicron(067310) Receives Conversion Request for 43.2B KRW in Convertible Bonds

Semiconductors
[Disclosure] Hanamicron(067310) Receives Conversion Request for 43.2B KRW in Convertible Bonds

[Disclosure] Hanamicron(067310) Receives Conversion Request for 43.2B KRW in Convertible Bonds

Semiconductors
[Disclosure] Samsung Biologics(207940) Approves KRW 3.69T Revenue and Appoints Suh Seoung-hwan as Outside Director at the 13th Annual General Meeting of Shareholders

[Disclosure] Samsung Biologics(207940) Approves KRW 3.69T Revenue and Appoints Suh Seoung-hwan as Outside Director at the 13th Annual General Meeting of Shareholders

Disclosures
[Disclosure] Jusung Engineering (036930) Obtains Unqualified Audit Opinion; Finalizes FY2023 Net Income at 34.0B Won Post-Audit Adjustments

[Disclosure] Jusung Engineering (036930) Obtains Unqualified Audit Opinion; Finalizes FY2023 Net Income at 34.0B Won Post-Audit Adjustments

Semiconductors
[Disclosure] HPSP(403870) Schedules AGM for March 29; Explains Overlap with ‘AGM Concentration Day’ Due to Tight Audit Timeline

[Disclosure] HPSP(403870) Schedules AGM for March 29; Explains Overlap with ‘AGM Concentration Day’ Due to Tight Audit Timeline

Semiconductors
[Disclosure] ISU PETASYS (007660) Files Reason for Holding AGM on Peak Corporate Date (March 29) to Accommodate Overseas Subsidiaries’ Audit Schedules

[Disclosure] ISU PETASYS (007660) Files Reason for Holding AGM on Peak Corporate Date (March 29) to Accommodate Overseas Subsidiaries’ Audit Schedules

Semiconductors
[Disclosure] SK Square (402340) Submits FY2023 Audit Report… Receives ‘Unqualified’ Opinion as Consolidated Operating Loss Fixed at KRW 2.34T

[Disclosure] SK Square (402340) Submits FY2023 Audit Report… Receives ‘Unqualified’ Opinion as Consolidated Operating Loss Fixed at KRW 2.34T

Semiconductors
[Disclosure] Samsung Biologics(207940) Signs KRW 92.8B CMO Contract with Merck Subsidiary

[Disclosure] Samsung Biologics(207940) Signs KRW 92.8B CMO Contract with Merck Subsidiary

Disclosures
[Disclosure] Alteogen(196170) Reports a 235% Surge in 2023 Consolidated Revenue to KRW 96.5B; Net Deficit Narrowed Significantly

[Disclosure] Alteogen(196170) Reports a 235% Surge in 2023 Consolidated Revenue to KRW 96.5B; Net Deficit Narrowed Significantly

Disclosures
[Disclosure] Alteogen(196170) Resolves to Convene Annual General Meeting of Shareholders on March 26; Nominates VP Tae-Yeon Jeon as Inside Director

[Disclosure] Alteogen(196170) Resolves to Convene Annual General Meeting of Shareholders on March 26; Nominates VP Tae-Yeon Jeon as Inside Director

Bio & Healthcare

Posts pagination

Previous 1 … 124 125 126 … 132 Next

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme